Dr. Marina Holz, assistant professor of biology at Yeshiva University’s Stern College for Women, is leading the charge in the fight against breast cancer. After receiving a $75,000 grant from the Elias Genevieve and Georgiana Atol Charitable Trust to research the molecular mechanisms of the S6 Kinase 1 (S6K1) gene, Holz was recently awarded a one-year $30,000 grant from the Wendy Will Case Cancer Fund to research the role of the mTOR (mammalian target of rapamycin) /S6K1 pathway in breast cancer.
Nathan Kahn, founder and CEO of Empire Resources Inc., in Fort Lee, N.J., has been elected to the Board of Overseers for Yeshiva University’s Albert Einstein College of Medicine.
Empire Resources is a public company with offices in North America, Europe and Australia. The Company distributes and manufactures aluminum products for sale to a wide array of industries for use in consumer products, automobiles, packaging, and housing materials.